InsideArbitrage Event Driven Monitor – April 3, 2025

Merger Arbitrage

1. ALLK: The acquisition of Allakos Inc. (ALLK) by Concentra Biosciences, LLC, for a closing value of $8.97 million. Under the terms of the agreement, Concentra Biosciences will acquire Allakos for $0.33 in cash per share of Allakos common stock. A wholly owned subsidiary of Concentra will commence a tender offer by April 15, 2025, to acquire all outstanding shares of Allakos common stock. (Press Release)
2. TGI: Triumph (TGI) filed the merger notification with the European Commission for its acquisition by Warburg Pincus and Berkshire Partners. The EU has set May 12, 2025, as the provisional deadline for its decision.
3. ENFN: Clearwater Analytics (CWAN) and Enfusion (ENFN) announced that the deadline for Enfusion shareholders of record to elect the form of merger consideration they wish to receive in connection with Clearwater’s acquisition of Enfusion is April 16, 2025. The parties expect to close the transaction on April 21, 2025.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.